Aptose Biosciences Inc (NAS:APTO)
$ 0.3737 0.0123 (3.4%) Market Cap: 6.62 Mil Enterprise Value: -1.11 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Aptose Biosciences Inc Annual Shareholders Meeting Transcript

Jun 01, 2021 / 05:00PM GMT
Release Date Price: $81.75 (+2.83%)
William G. Rice
Aptose Biosciences Inc. - Chairman, President & CEO

Good morning, all. I would like to call to order this Annual Meeting of Shareholders of Aptose Biosciences Incorporated. I'm Dr. William Rice, Chairman of the Board of Directors, President and Chief Executive Officer of Aptose, and I'll be serving as the chair of today's meeting.

Joining me today online are other directors, including Dr. Dennis Burger, who's our Lead Independent Director; Dr. Erich Platzer; Mr. Warren Whitehead; Ms. Carol Ashe; Ms. Caroline Loewy; and Dr. Mark Vincent. Other company officers also joining us online today are Dr. Joti Marango, Senior Vice President, Chief Business Officer and Chief Financial Officer; and Dr. Rafael Bejar, Senior Vice President and Chief Medical Officer.

It's my pleasure to welcome the shareholders and employees of Aptose and other invited guests to this meeting. As in 2020, considering concerns regarding the COVID-19 pandemic, Aptose has opted for a virtual

(technical difficulty)

our thoughts are with you. And we have ensured this virtual meeting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot